NMD Pharma at ICFSR 2022 - Symposium 4 - Part 4 - Q&A

Events

Aug 16

Written By Stine Krag Brunvold

Neuromuscular Junction Transmission Failure in Sarcopenia

See the ICFSR program here:

Stine Krag Brunvold

NMD Pharma at ICFSR 2022 - Symposium 4 - Part 3

Spinal Muscular Atrophy (SMA) Patient Perspective: Our Clinical Trial Manager Thomas Grønnebæk caught up with Eden